LOETTE

This brand name is authorized in Austria, Estonia, Spain, Hong Kong, Lithuania, New Zealand, South Africa

Active ingredients

The drug LOETTE contains a combination of these active pharmaceutical ingredients (APIs):

1 Levonorgestrel UNII 5W7SIA7YZW - LEVONORGESTREL

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. Read about Levonorgestrel

2 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOETTE Tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AA07	Levonorgestrel and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1088029, 1088030
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65067, 66628
Country: HK	Department of Health Drug Office	Identifier(s): 53602
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008612, 1008613
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7912
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/21.8.2/0054